GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Baijin Life Science Holdings Ltd (HKSE:01466) » Definitions » EV-to-Revenue

Baijin Life Science Holdings (HKSE:01466) EV-to-Revenue : 5.61 (As of May. 04, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Baijin Life Science Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Baijin Life Science Holdings's enterprise value is HK$558.29 Mil. Baijin Life Science Holdings's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was HK$99.46 Mil. Therefore, Baijin Life Science Holdings's EV-to-Revenue for today is 5.61.

The historical rank and industry rank for Baijin Life Science Holdings's EV-to-Revenue or its related term are showing as below:

HKSE:01466' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.24   Med: 3.74   Max: 13.17
Current: 5.61

During the past 11 years, the highest EV-to-Revenue of Baijin Life Science Holdings was 13.17. The lowest was 0.24. And the median was 3.74.

HKSE:01466's EV-to-Revenue is ranked worse than
91.85% of 1117 companies
in the Retail - Cyclical industry
Industry Median: 0.86 vs HKSE:01466: 5.61

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-05-04), Baijin Life Science Holdings's stock price is HK$0.73. Baijin Life Science Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was HK$0.15. Therefore, Baijin Life Science Holdings's PS Ratio for today is 4.93.


Baijin Life Science Holdings EV-to-Revenue Historical Data

The historical data trend for Baijin Life Science Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baijin Life Science Holdings EV-to-Revenue Chart

Baijin Life Science Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.62 0.93 0.75 4.78 8.78

Baijin Life Science Holdings Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.78 - 8.78 -

Competitive Comparison of Baijin Life Science Holdings's EV-to-Revenue

For the Luxury Goods subindustry, Baijin Life Science Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baijin Life Science Holdings's EV-to-Revenue Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Baijin Life Science Holdings's EV-to-Revenue falls into.


;
;

Baijin Life Science Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Baijin Life Science Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=558.285/99.455
=5.61

Baijin Life Science Holdings's current Enterprise Value is HK$558.29 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Baijin Life Science Holdings's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was HK$99.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baijin Life Science Holdings  (HKSE:01466) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Baijin Life Science Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.73/0.148
=4.93

Baijin Life Science Holdings's share price for today is HK$0.73.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2024 was HK$0.15.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baijin Life Science Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Baijin Life Science Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Baijin Life Science Holdings Business Description

Traded in Other Exchanges
Address
66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company produces health products that are affordable for the general public. The business segments of the company are Life Science segment which includes cellular technology-based services, provide including cellular drugs R&D, large molecule drugs R&D, clinical research services and R&D and sales on self-owned skincare brand, and Fine Jewelry segment that focuses on the procurement, processing, design, production and wholesale distribution of pearls and fine jewelry products.
Executives
Pacific Wish Limited
Chan Vincent Wing Sing
Hui Ka Man Emily
Ketto Inform Limited 2101 Beneficial owner
Su Yaoyao 2201 Interest of corporation controlled by you

Baijin Life Science Holdings Headlines

No Headlines